跳至主要内容
临床试验/IRCT20171028037047N1
IRCT20171028037047N1招募中4 期

Comparison of ezetimibe and atorvastatin treatment versus atorvastatin alone on Major Adverse Cardiac Events (MACE) after elective percutaneous coronary intervention (PCI)

Bandare-abbas University of Medical Sciences0 个研究点目标入组 224 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
224

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients who are candidates for elective PCI
  • Having normal hepatic enzymes
  • Having negative troponin
  • Having LDL values greater than 100 mg / d

排除标准

  • Having Inflammatory and rheumatologic diseases
  • Having Infectious diseases
  • Having malignancies
  • Having high creatinine levels
  • Having abnormal liver enzymes
  • Pregnancy and lactation
  • Use of NSAIDs
  • Patient's dissatisfaction with participating in the study
  • Having ejection fraction below 30 (EF < 30)
  • Having myocardial infarction in the last month
  • The increase in troponin after PCI more than 5 times higher than normal maximum of 99 percentile

研究者

发起方
Bandare-abbas University of Medical Sciences

相似试验